Stock Events

Stock Events

Mera Pharmaceuticals 

$0.000100
3
+$0.00+0% Monday 20:00
-$0.00-99%Tuesday 20:03After hours

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.0001
52W Low
0.0001
Volume
4,419,177
Avg. Volume
2,001
Mkt Cap
0
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

31JulExpected
Q4 2010
Q1 2011
Q2 2011
Q3 2011
Q2 2020
Q3 2020
Q2 2021
-0
-0
-0
0
Expected EPS
0
Actual EPS
0

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences is a biopharmaceutical company that develops and markets drugs in similar therapeutic areas as Mera Pharmaceuticals.
AMGEN
AMGN
Mkt Cap233.78B
Amgen is a biotech firm focusing on novel therapies in areas like cardiovascular disease, which overlaps with some of Mera Pharmaceuticals' interests.
Vertex Pharmaceuticals
VRTX
Mkt Cap137.3B
Vertex Pharmaceuticals engages in creating drugs for complex diseases, competing in the innovation-driven pharmaceuticals market alongside Mera Pharmaceuticals.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals is known for its innovation in biopharmaceuticals, directly competing with Mera Pharmaceuticals in drug development and commercialization.
Biogen
BIIB
Mkt Cap32.28B
Biogen focuses on neurological diseases and advanced therapies, sharing a competitive space with Mera Pharmaceuticals in biotechnological advancements.
Incyte
INCY
Mkt Cap25.21B
Incyte Corporation operates in the same biopharmaceutical field, developing drugs that could be in direct competition with Mera Pharmaceuticals' products.
Exelixis
EXEL
Mkt Cap13.49B
Exelixis is involved in the discovery, development, and commercialization of new medicines, potentially competing with Mera Pharmaceuticals in certain therapeutic areas.

About

Mera Pharmaceuticals, Inc. focuses on the development and commercialization of natural products from microalgae using its proprietary and large-scale photobioreactor technology. The company is also involved in the development of sea salt; and operation of family entertainment center focused on promoting health and wellness through the Villari’s system of martial arts. In addition, it provides food production and delivery services. Mera Pharmaceuticals, Inc. was founded in 1983 and is based in Las Vegas, Nevada.
Show more...
CEO
Benny Doro
Employees
74
Country
United States
ISIN
US58732R1032

Listings

OTC Link
US
MRPI

0 Comments

Share your thoughts

FAQ

What is Mera Pharmaceuticals stock price today?▼
The current price of MRPI is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Mera Pharmaceuticals stock price performance more closely on the chart.
What is Mera Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Mera Pharmaceuticals stocks are traded under the ticker MRPI.
Is Mera Pharmaceuticals stock price growing?▼
MRPI stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Mera Pharmaceuticals has showed a +0% increase.
What were Mera Pharmaceuticals earnings last quarter?▼
MRPI earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a +NaN% surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Mera Pharmaceuticals have?▼
As of September 03, 2026, the company has 74 employees.
In which sector is Mera Pharmaceuticals located?▼
Mera Pharmaceuticals operates in the Health & Wellness sector.
When did Mera Pharmaceuticals complete a stock split?▼
Mera Pharmaceuticals has not had any recent stock splits.
Where is Mera Pharmaceuticals headquartered?▼
Mera Pharmaceuticals is headquartered in Las Vegas, United States.